Wave Life Sciences: 200% Rally On 1% Weight Loss Feels Bloated [Seeking Alpha]
Wave Life Sciences Ltd. - Ordinary Shares (WVE)
Last wave life sciences ltd. - ordinary shares earnings: 3/2 06:45 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.wavelifesciences.com/news-releases?page=1%2c0%2c0%2c0
Company Research
Source: Seeking Alpha
WVE-007's efficacy in obesity remains unproven versus GLP-1s, with no clear skeletal muscle sparing or cardiometabolic benefit in healthy overweight subjects. Management pivots the narrative from weight loss to body composition, yet statistical significance and clinical impact remain lacking in current data. Wave Life Sciences' $3.5B valuation reflects both pipeline risk and opportunity; further clinical validation in higher-risk populations is essential for upside. Staras/iStock via Getty Images Introduction My last look at Wave Life Sciences ( WVE ) was in March 2024. Back then, Wave had just announced its lead candidate for the treatment of obesity. Wave decided to pursue the loss-of-function of the INHBE gene, which This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expre
Show less
Read more
Impact Snapshot
Event Time:
WVE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WVE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WVE alerts
High impacting Wave Life Sciences Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
WVE
News
- WAVE Life Sciences (NASDAQ:WVE) had its "buy" rating reaffirmed by analysts at B. Riley.MarketBeat
- WAVE Life Sciences (NASDAQ:WVE) had its "outperform" rating reaffirmed by analysts at Wedbush.MarketBeat
- Wave Life Science prices upsized $350M stock ofeering [Seeking Alpha]Seeking Alpha
- Wave Life Sciences Prices Upsized $350 Million Public Offering of Ordinary Shares and Pre-Funded Warrants [Yahoo! Finance]Yahoo! Finance
- Wave Life Sciences Prices Upsized $350 Million Public Offering of Ordinary Shares and Pre-Funded WarrantsGlobeNewswire
WVE
Earnings
- 11/10/25 - Miss
WVE
Sec Filings
- 12/11/25 - Form 424B5
- 12/11/25 - Form 8-K
- 12/10/25 - Form 4
- WVE's page on the SEC website